Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 86

Published Date: 11 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.

According to our (Global Info Research) latest study, the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The high efficacy of EGFR inhibitors in the treatment of various types of cancer indications has encouraged researchers to study its use in the treatment of inflammatory and monogenic diseases. Recent in-vitro research studies have suggested that EGFR mutations may cause indications such as eczema, psoriasis, and atherosclerosis. Although these studies are in the early stages of clinical trials, the huge unmet need and further advancements in research are expected to brighten the growth prospects of EGFR inhibitors market vendors in new research areas.

This report is a detailed and comprehensive analysis for global Epidermal Growth Factor Receptor (EGFR) Inhibitor market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size and forecasts, in consumption value ($ Million), 2018-2029
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epidermal Growth Factor Receptor (EGFR) Inhibitor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd. and Novartis AG. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Epidermal Growth Factor Receptor (EGFR) Inhibitor market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Lung Cancer
Colorectal Cancer
Breast Cancer
Others

Market segment by Application
Hospital
Research Institutes and Research Institutions
Clinic
Other

Market segment by players, this report covers
Amgen Inc.
AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Epidermal Growth Factor Receptor (EGFR) Inhibitor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, with revenue, gross margin and global market share of Epidermal Growth Factor Receptor (EGFR) Inhibitor from 2018 to 2023.
Chapter 3, the Epidermal Growth Factor Receptor (EGFR) Inhibitor competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Epidermal Growth Factor Receptor (EGFR) Inhibitor market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Epidermal Growth Factor Receptor (EGFR) Inhibitor.
Chapter 13, to describe Epidermal Growth Factor Receptor (EGFR) Inhibitor research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Epidermal Growth Factor Receptor (EGFR) Inhibitor
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Epidermal Growth Factor Receptor (EGFR) Inhibitor by Type
        1.3.1 Overview: Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type in 2022
        1.3.3 Lung Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Breast Cancer
        1.3.6 Others
    1.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market by Application
        1.4.1 Overview: Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Research Institutes and Research Institutions
        1.4.4 Clinic
        1.4.5 Other
    1.5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size & Forecast
    1.6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast by Region
        1.6.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region, (2018-2029)
        1.6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Prospect (2018-2029)
        1.6.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Prospect (2018-2029)
        1.6.6 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Amgen Inc.
        2.1.1 Amgen Inc. Details
        2.1.2 Amgen Inc. Major Business
        2.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
        2.1.4 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Amgen Inc. Recent Developments and Future Plans
    2.2 AstraZeneca Plc
        2.2.1 AstraZeneca Plc Details
        2.2.2 AstraZeneca Plc Major Business
        2.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
        2.2.4 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 AstraZeneca Plc Recent Developments and Future Plans
    2.3 Eli Lilly and Co.
        2.3.1 Eli Lilly and Co. Details
        2.3.2 Eli Lilly and Co. Major Business
        2.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
        2.3.4 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Eli Lilly and Co. Recent Developments and Future Plans
    2.4 F. Hoffmann-La Roche Ltd.
        2.4.1 F. Hoffmann-La Roche Ltd. Details
        2.4.2 F. Hoffmann-La Roche Ltd. Major Business
        2.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
        2.4.4 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
    2.5 Novartis AG
        2.5.1 Novartis AG Details
        2.5.2 Novartis AG Major Business
        2.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
        2.5.4 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Novartis AG Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Epidermal Growth Factor Receptor (EGFR) Inhibitor by Company Revenue
        3.2.2 Top 3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share in 2022
        3.2.3 Top 6 Epidermal Growth Factor Receptor (EGFR) Inhibitor Players Market Share in 2022
    3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Overall Company Footprint Analysis
        3.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Region Footprint
        3.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Company Product Type Footprint
        3.3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application (2018-2023)
    5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2029)
    6.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2029)
    6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        6.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2029)
        6.3.2 United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        6.3.3 Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        6.3.4 Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2029)
    7.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2029)
    7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        7.3.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2029)
        7.3.2 Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        7.3.3 France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        7.3.5 Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        7.3.6 Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region
        8.3.1 Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Region (2018-2029)
        8.3.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        8.3.3 Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        8.3.4 South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        8.3.5 India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        8.3.7 Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2029)
    9.2 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2029)
    9.3 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        9.3.1 South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2029)
        9.3.2 Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        9.3.3 Argentina Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
        10.3.1 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2029)
        10.3.2 Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)
        10.3.4 UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
    11.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints
    11.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Chain
    12.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Upstream Analysis
    12.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Midstream Analysis
    12.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Amgen Inc. Company Information, Head Office, and Major Competitors
    Table 6. Amgen Inc. Major Business
    Table 7. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
    Table 8. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Amgen Inc. Recent Developments and Future Plans
    Table 10. AstraZeneca Plc Company Information, Head Office, and Major Competitors
    Table 11. AstraZeneca Plc Major Business
    Table 12. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
    Table 13. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. AstraZeneca Plc Recent Developments and Future Plans
    Table 15. Eli Lilly and Co. Company Information, Head Office, and Major Competitors
    Table 16. Eli Lilly and Co. Major Business
    Table 17. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
    Table 18. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Eli Lilly and Co. Recent Developments and Future Plans
    Table 20. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
    Table 21. F. Hoffmann-La Roche Ltd. Major Business
    Table 22. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
    Table 23. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
    Table 25. Novartis AG Company Information, Head Office, and Major Competitors
    Table 26. Novartis AG Major Business
    Table 27. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product and Solutions
    Table 28. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Novartis AG Recent Developments and Future Plans
    Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (USD Million) by Players (2018-2023)
    Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Share by Players (2018-2023)
    Table 32. Breakdown of Epidermal Growth Factor Receptor (EGFR) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 33. Market Position of Players in Epidermal Growth Factor Receptor (EGFR) Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 34. Head Office of Key Epidermal Growth Factor Receptor (EGFR) Inhibitor Players
    Table 35. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Company Product Type Footprint
    Table 36. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market: Company Product Application Footprint
    Table 37. Epidermal Growth Factor Receptor (EGFR) Inhibitor New Market Entrants and Barriers to Market Entry
    Table 38. Epidermal Growth Factor Receptor (EGFR) Inhibitor Mergers, Acquisition, Agreements, and Collaborations
    Table 39. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (USD Million) by Type (2018-2023)
    Table 40. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Share by Type (2018-2023)
    Table 41. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Forecast by Type (2024-2029)
    Table 42. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2023)
    Table 43. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Forecast by Application (2024-2029)
    Table 44. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
    Table 45. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
    Table 46. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
    Table 47. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
    Table 48. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 49. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 50. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
    Table 53. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
    Table 54. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 55. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 56. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
    Table 57. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
    Table 58. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
    Table 59. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
    Table 60. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Region (2018-2023) & (USD Million)
    Table 61. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Region (2024-2029) & (USD Million)
    Table 62. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
    Table 63. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
    Table 64. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
    Table 65. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
    Table 66. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2018-2023) & (USD Million)
    Table 69. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type (2024-2029) & (USD Million)
    Table 70. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2018-2023) & (USD Million)
    Table 71. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Application (2024-2029) & (USD Million)
    Table 72. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2018-2023) & (USD Million)
    Table 73. Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Country (2024-2029) & (USD Million)
    Table 74. Epidermal Growth Factor Receptor (EGFR) Inhibitor Raw Material
    Table 75. Key Suppliers of Epidermal Growth Factor Receptor (EGFR) Inhibitor Raw Materials
List of Figures
    Figure 1. Epidermal Growth Factor Receptor (EGFR) Inhibitor Picture
    Figure 2. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type in 2022
    Figure 4. Lung Cancer
    Figure 5. Colorectal Cancer
    Figure 6. Breast Cancer
    Figure 7. Others
    Figure 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application in 2022
    Figure 10. Hospital Picture
    Figure 11. Research Institutes and Research Institutions Picture
    Figure 12. Clinic Picture
    Figure 13. Other Picture
    Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Region in 2022
    Figure 19. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Share by Players in 2022
    Figure 25. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share in 2022
    Figure 27. Global Top 6 Players Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share in 2022
    Figure 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Share by Type (2018-2023)
    Figure 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Type (2024-2029)
    Figure 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Share by Application (2018-2023)
    Figure 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share Forecast by Application (2024-2029)
    Figure 32. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Epidermal Growth Factor Receptor (EGFR) Inhibitor Consumption Value (2018-2029) & (USD Million)
    Figure 66. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
    Figure 67. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints
    Figure 68. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor in 2022
    Figure 71. Manufacturing Process Analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor
    Figure 72. Epidermal Growth Factor Receptor (EGFR) Inhibitor Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen Inc.
AstraZeneca Plc
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Novartis AG

Related Reports

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Supply, Demand and Key Producers, 2023-2029

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Supply, Demand and Key Producers, 2023-2029

date 19 Jan 2023

date Pharma & Healthcare

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Epidermal Growth Factor Receptor (EGFR) Inhibitor

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>